Fate Therapeutics
FATE
FATE
248 hedge funds and large institutions have $7.94B invested in Fate Therapeutics in 2020 Q4 according to their latest regulatory filings, with 67 funds opening new positions, 72 increasing their positions, 94 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
1.55% less ownership
Funds ownership: 101.12% → 99.57% (-1.5%)
12% less call options, than puts
Call options by funds: $17.2M | Put options by funds: $19.5M
23% less repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 94
Holders
248
Holding in Top 10
14
Calls
$17.2M
Puts
$19.5M
Top Buyers
| 1 | +$90.8M | |
| 2 | +$72.9M | |
| 3 | +$54.9M | |
| 4 |
Morgan Stanley
New York
|
+$42.9M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$39.3M |
Top Sellers
| 1 | -$92.1M | |
| 2 | -$54.4M | |
| 3 | -$49.4M | |
| 4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
-$45.1M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$42.4M |